The Patent Finder

NexusPharma, Inc.

Also on record
Records under this name other than the patents NexusPharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to NexusPharma, Inc.

PatentTitleStatus Expires Confidence
US 8,426,466Compositions and methods for enhancing active agent absorption
Lapsed on the fee record
Ended Apr 23, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 23, 2025From the USPTO record
US 8,367,699Tetrahydro-isoquinolines
Lapsed on the fee record
Ended Feb 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 5, 2025From the USPTO record
US 8,163,744Tetrahydro-isoquinolin-1-ones for the treatment of cancer
Lapsed on the fee record
Ended Apr 24, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2024From the USPTO record
US 9,149,530Compositions and methods for enhancing active agent absorption
Lapsed on the fee record
Ended Oct 6, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 6, 2023From the USPTO record
US 7,705,021Isoindolone Compounds, Compositions Containing the Same, and Methods of Use Thereof for the Treatment of Viral Infections Related to the Etiology of Cancer
Formerly held
Lapsed on the fee record
Ended Apr 27, 2022 · High confidence
Lapsed on the fee recordEnded Apr 27, 2022High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited